RENAISSANCE TECHNOLOGIES LLC

Position in LENZ — LENZ Therapeutics, Inc.

CIK 1037389 NEW YORK, NY

Position in LENZ

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$401,167

-$331,149 QoQ

Shares Held

70,628

+178.4% QoQ

Ownership

0.225%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#50

of 143 holders

Holding Since

Jun 2022

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

RENAISSANCE TECHNOLOGIES LLC holds $3,952,579,858 across 312 Biotechnology names. LENZ ranks #223 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	EXEL	Exelixis, Inc.	13,427,993	$730,617,099
2	CORT	Corcept Therapeutics Inc	5,261,628	$457,498,554
3	INCY	Incyte Corp	3,512,132	$398,135,283
4	VRTX	Vertex Pharmaceuticals Inc / Ma	320,008	$158,957,573
5	JAZZ	Jazz Pharmaceuticals plc	562,073	$135,442,730
6	RPRX	Royalty Pharma plc	1,935,800	$108,540,306
7	TVTX	Travere Therapeutics, Inc.	1,833,079	$104,137,217
8	GMAB	Genmab A/S	3,517,850	$96,635,339

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$401,167	70,628	+178.4%	Shares	Sole	2026-08-13
2024-12-31	$732,316	25,366	-48.5%	Shares	Sole	2025-02-13
2024-09-30	$1,169,574	49,266	-18.1%	Shares	Sole	2024-11-13
2024-06-30	$1,040,270	60,166	+28.4%	Shares	Sole	2024-08-09
2024-03-31	$1,046,517	46,866	—	Shares	Sole	2024-05-13
2023-12-31 GRPH	—	581,156	+119.8%	Shares	Sole	2024-02-13
2023-09-30 GRPH	—	264,400	+8.3%	Shares	Sole	2023-11-14
2023-06-30 GRPH	—	244,100	+7.0%	Shares	Sole	2023-08-11
2023-03-31 GRPH	—	228,200	-30.8%	Shares	Sole	2023-05-12
2022-12-31 GRPH	—	329,872	-36.8%	Shares	Sole	2023-02-13
2022-09-30 GRPH	—	521,969	-33.7%	Shares	Sole	2022-11-14
2022-06-30 GRPH	—	787,300	—	Shares	Sole	2022-08-12
No filing history on record for this holder in this stock.